Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA Gets A New Lawyer: Rebecca Wood Named Chief Counsel

Executive Summary

Former Sidley Austin partner brings a wealth of experience in drug product liability litigation and federal preemption. She replaces agency veteran Elizabeth Dickinson, who will stay on as senior deputy to the chief counsel.

You may also be interested in...

Generic Labeling Rule: Will Delay Spell Doom?

FDA aims to finalize proposed reg that would allow ANDA holders to unilaterally make safety labeling changes by July 2016, but opposition continues to swirl.

Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing

“Expedited Agency Review” idea would require an FDA review of proposed safety-related labeling changes before they are made and end the CBE-0 system brand companies already use and generics could be required to adopt.

FDA Generic Labeling Rule: PhRMA, GPhA Offer Degrees Of Dislike

GPhA argues it would be impossible for ANDA applicants to unilaterally change their labels; Pfizer suggests FDA only allow one request for a proposed labeling change on a given safety issue at a time.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts